These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8649463

  • 1. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine.
    Gundy S, Katz N, Füzy M, Esik O.
    Mutat Res; 1996 Jun 10; 360(2):107-13. PubMed ID: 8649463
    [Abstract] [Full Text] [Related]

  • 2. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N, Esik O, Füzy M, Gundy S.
    Orv Hetil; 1998 Jun 21; 139(25):1521-6. PubMed ID: 9676113
    [Abstract] [Full Text] [Related]

  • 3. A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma.
    Llloyd DC, Purrott RJ, Dolphin GW, Horton PW, Halnan KE, Scott JS, Mair G.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Nov 21; 30(5):473-85. PubMed ID: 1087288
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.
    Khvostunov IK, Saenko VA, Krylov V, Rodichev A, Yamashita S.
    Radiat Environ Biophys; 2017 Aug 21; 56(3):213-226. PubMed ID: 28526978
    [Abstract] [Full Text] [Related]

  • 5. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
    Ceccarelli C, Battisti P, Gasperi M, Fantuzzi E, Pacini F, Gualdrini G, Pierantoni MC, Luciani A, Djokich D, Pinchera A.
    J Nucl Med; 1999 Oct 21; 40(10):1716-21. PubMed ID: 10520714
    [Abstract] [Full Text] [Related]

  • 6. Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments.
    da Silva MA, Valgôde FG, Gonzalez JA, Yoriyaz H, Guimarães MI, Ribela MT, Buchpiguel CA, Bartolini P, Okazaki K.
    Radiat Environ Biophys; 2016 Aug 21; 55(3):317-28. PubMed ID: 27013085
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D, M'Kacher R, Adjadj E, Dossou J, de Vathaire F, Parmentier C.
    Eur J Nucl Med Mol Imaging; 2005 Feb 21; 32(2):174-9. PubMed ID: 15449047
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B, Hoekstra A, Konijnenberg MW, de Vos F, Lambert B, van Rijk PP, Lips CJ, de Klerk JM.
    J Nucl Med; 2004 Sep 21; 45(9):1549-54. PubMed ID: 15347723
    [Abstract] [Full Text] [Related]

  • 11. Cytogenetic effects of radioiodine therapy: a 20-year follow-up study.
    Livingston GK, Khvostunov IK, Gregoire E, Barquinero JF, Shi L, Tashiro S.
    Radiat Environ Biophys; 2016 May 21; 55(2):203-13. PubMed ID: 27015828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, Parmentier C.
    J Nucl Med; 1996 Nov 21; 37(11):1860-4. PubMed ID: 8917193
    [Abstract] [Full Text] [Related]

  • 20. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
    Watanabe N, Yokoyama K, Kinuya S, Shuke N, Shimizu M, Futatsuya R, Michigishi T, Tonami N, Seto H, Goodwin DA.
    J Nucl Med; 1998 Mar 21; 39(3):436-40. PubMed ID: 9529288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.